# OS Therapies Incorporated (OSTX)

OS Therapies (OSTX) CEO discusses novel HER2-targeted immunotherapy for osteosarcoma on Cell & Gene podcast, following positive Phase 2B trial results and FDA filing progress.

### About OS Therapies Incorporated
OS Therapies Incorporated is a biotechnology company focused on developing novel therapies for cancer treatment.  
OS Therapies Incorporated uses the ticker $OSTX for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- OS Therapies Incorporated (OSTX) social dominance hit [------] which is 162% higher than it's daily average.
- OS Therapies Incorporated (OSTX) trading volume is up 110.92% from the previous month.
- OS Therapies Incorporated (OSTX) social dominance is up 869.23% from the previous [--] months.
- OS Therapies Incorporated (OSTX) Galaxy Score™ is up 25% from the previous week.

### Price: $1.20
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/close.tsv)  
The stock price is driven by positive clinical trial results and FDA filing progress, leading to a 52-week high, though a slight 24-hour dip suggests potential profit-taking.  

24-Hour: 5.17%
7-Day: -12.23%
30-Day: -16.44%

1-Year High: $2.50 on 2025-08-27  
1-Year Low: $1.20 on 2026-02-12  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/alt_rank.tsv)  
OS Therapies Incorporated (OSTX) is currently AltRank #1,936 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,769  
1-Year High: [-----] on 2026-02-11  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +6  
1-Year High: [--] on 2026-01-26  
1-Year Low: [--] on 2026-01-30  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] -11%  
[--] Month: [------] -14%  
[--] Months: [-------] -32%  
[--] Year: [---------] +19%  
1-Year High: [------] on 2025-02-18  
1-Year Low: [--] on 2025-05-09  

Engagements by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +6.70%  
1-Year High: [---] on 2025-07-04  
1-Year Low: [--] on 2025-05-09  

Mentions by network (24h):
TikTok: [--]
Reddit: [--]
YouTube: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning OS Therapies Incorporated (OSTX) in the last [--] hours which is down 6.40% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +3.10%  
1-Year High: [---] on 2025-07-17  
1-Year Low: [--] on 2025-05-09  

The most influential creators that mention OS Therapies Incorporated in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@OSTherapies](/creator/twitter/OSTherapies)         | [--]    | [---]       | [--]    | [---]         |
| [@Lola_La_Fleur_](/creator/twitter/Lola_La_Fleur_)   | [--]    | [--]        | [--]     | [--]          |
| [@Stmkrs](/creator/twitter/Stmkrs)                   | [--]    | [---]       | [--]     | [--]          |
| [@ArundhatiRashmi](/creator/twitter/ArundhatiRashmi) | [--]    | [--]        | [--]     | [--]          |
| [@MaisaCorp](/creator/twitter/MaisaCorp)             | [--]    | [-----]     | [--]     | [--]          |
| [@Lycanbull](/creator/twitter/Lycanbull)             | [--]    | [-----]     | [--]     | [--]           |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | [--]    | [-----]     | [--]     | [--]           |
| [@ahmedab64401699](/creator/twitter/ahmedab64401699) | [--]    | [--]        | [--]     | [--]           |
| [@TradershubNinja](/creator/twitter/TradershubNinja) | [--]    | [-----]     | [--]     | [--]           |
| [@BollwerkAI](/creator/twitter/BollwerkAI)           | [--]   | [---]       | [--]     | [--]           |

[View More](/list/creators/os-therapies-incorporated/100)
  
  
### Sentiment: 95%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/sentiment.tsv)  
Current Value: 95%  
Daily Average: 92%  
[--] Week: 93% -7%  
[--] Month: 91% -2%  
[--] Months: 91% +11%  
[--] Year: 91% +17%  
1-Year High: 100% on 2025-02-20  
1-Year Low: 33% on 2025-03-17  

Most Supportive Themes:
- Positive Clinical Trial Results: (70%) OS Therapies Incorporated (OSTX) has announced positive clinical trial results for its OST-HER2 therapy, showing a significant benefit in preventing or delaying recurrent pulmonary metastatic osteosarcoma.
- FDA Filing and Review Process: (20%) The company has initiated the US FDA Biologics License Application (BLA) filing for OST-HER2 and is engaging in discussions with the FDA regarding biomarker data, indicating progress in the regulatory pathway.
  
Most Critical Themes:
- Market Volatility and Profit-Taking: (15%) Despite positive news, the stock experienced a slight 24-hour dip, suggesting potential profit-taking or short-term market fluctuations that could impact the stock price.
  
  
  
### Social Dominance: 0.00512%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/social_dominance.tsv)  
Current Value: 0.00512%  
Daily Average: 0.00481%  
[--] Week: 0.00513% +0.00383%  
[--] Month: 0.013% +0.0044%  
[--] Months: 0.013% +0.01%  
[--] Year: 0.013% -0.015%  
1-Year High: 0.04% on 2025-07-04  
1-Year Low: 0.0001% on 2025-10-05  
  
  
### Market Dominance: 0.0000486521702880182%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/market_dominance.tsv)  
Current Value: 0.0000486521702880182%  
Daily Average: 0%  
1-Year High: 0.00006% on 2026-01-13  
1-Year Low: 0.00005% on 2026-02-04  
  
  
### Market Cap: $42,961,509
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:os-therapies-incorporated/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/os-therapies-incorporated/time-series/market_cap.tsv)  
Current Value: $42,961,509  
Daily Average: $48,990,633  
[--] Week: $43,313,653 -12%  
[--] Month: $42,961,509 -16%  
1-Year High: $54,582,246 on 2026-01-14  
1-Year Low: $40,848,648 on 2026-02-12  

### Top OS Therapies Incorporated Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"New podcast 🎙 CEO Paul Romness joins Cell & Gene: The Podcast to share how OS Therapies is tackling pulmonary metastatic osteosarcoma with a HER2-targeted immunotherapy approach and insights from a recent Phase 2B trial. Listen here with a free subscription or on your favorite podcast platform: $OSTX https://bit.ly/4csuM0i https://bit.ly/4csuM0i"  
[X Link](https://x.com/OSTherapies/status/2022362717303067034) [@OSTherapies](/creator/x/OSTherapies) 2026-02-13T17:30Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing